(HealthDay)—Considerable practice variation exists among surgeons at a high-volume academic center when selecting patients with prostate cancer to undergo radical prostatectomy, according to a study published in the March ...
Feb 16, 2015
0
4
Despite strong evidence and guidelines supporting its use, post-surgical radiation therapy for prostate cancer patients at risk of recurrence is declining in the United States. The study, published online in the journal European ...
Apr 20, 2015
0
5
(HealthDay)—Additional predictors, such as prostate-specific antigen (PSA) density and extent of cancer on biopsy, help guide selection of prostate cancer patients for active surveillance programs, according to research ...
Jan 24, 2014
0
0
(HealthDay)—Penile thermal sensory thresholds increase after non-nerve-sparing radical prostatectomy (RP) but not after the nerve-sparing procedure, according to a study published in the September issue of The Journal of ...
Sep 13, 2012
0
0
(HealthDay)—Adjuvant radiotherapy does not improve event-free survival in men with localized or locally advanced prostate cancer treated with radical prostatectomy, according to a review and meta-analysis published online ...
Oct 5, 2020
0
3
Men with prostate cancer who consumed green tea prior to undergoing prostatectomy had reductions in markers of inflammation, according to data presented at the 11th Annual AACR International Conference on Frontiers in Cancer ...
Oct 19, 2012
0
0
(HealthDay)—For patients newly diagnosed with prostate cancer who attend a multidisciplinary clinic, decisional regret does not differ significantly between treatment groups, according to a study published online July 5 ...
Jul 11, 2017
0
1
(HealthDay)—For men with low-risk prostate cancer, vascular targeted photodynamic therapy achieves an 82 percent rate of absent clinically significant cancer in treated lobes, according to a study published in the August ...
Jul 25, 2017
0
1
Among men who had undergone radical prostatectomy, daily consumption of a beverage powder supplement containing soy protein isolate for 2 years did not reduce or delay development of biochemical recurrence of prostate cancer ...
Jul 9, 2013
0
0
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
May 16, 2012
0
0
